Abrysvo™ (respiratory syncytial virus vaccine) – New vaccine approval
May 31, 2023 - Pfizer announced the FDA approval of Abrysvo (respiratory syncytial virus vaccine), for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older.
Top